Cargando…

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug

Bisphosphonates have benefits in breast cancer and multiple myeloma patients and have been used with adoptive immunotherapy with γδ T cells expressing Vγ2 Vδ2 TCRs. Although treatment with γδ T cells is safe, it has shown limited efficacy. Present bisphosphonates stimulate γδ T cells but were design...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Yoshimasa, Iwasaki, Masashi, Murata-Hirai, Kaoru, Matsumoto, Kenji, Hayashi, Kosuke, Okamura, Haruki, Sugie, Tomoharu, Minato, Nagahiro, Morita, Craig T., Toi, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519590/ https://www.ncbi.nlm.nih.gov/pubmed/28729550 http://dx.doi.org/10.1038/s41598-017-05553-0

Ejemplares similares

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug
por: Tanaka, Yoshimasa, et al.
Publicado: (2018)

Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol
por: Sumi, Eriko, et al.
Publicado: (2014)

Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells
por: Okuno, Daisuke, et al.
Publicado: (2020)

Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanions
por: Rudge, Emma S., et al.
Publicado: (2022)

Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs
por: Grajkowski, Andrzej, et al.
Publicado: (2005)

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
por: Wang, Yizheng, et al.
Publicado: (2023)

The impact of senescence-associated T cells on immunosenescence and age-related disorders
por: Fukushima, Yuji, et al.
Publicado: (2018)

Physiology and pathology of T-cell aging
por: Minato, Nagahiro, et al.
Publicado: (2020)

Protocol for the isolation of mouse senescence-associated CD4(+) T cells using flow cytometry and functional assays
por: Fukushima, Yuji, et al.
Publicado: (2023)

A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer
por: Sugie, Tomoharu, et al.
Publicado: (2010)

Rap Signaling in Normal Lymphocyte Development and Leukemia Genesis
por: Minato, Nagahiro
Publicado: (2009)

Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer
por: Kawaguchi, Kosuke, et al.
Publicado: (2016)

Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
por: Kawasaki, Yoshiko, et al.
Publicado: (2011)

Dramatic Recovery of Vision after Trastuzumab Deruxtecan Treatment of HER2-Positive Breast Cancer with Pituitary Metastasis
por: Matsui, Chiaki, et al.
Publicado: (2023)

Effects after starting or switching from bisphosphonate to romosozumab or denosumab in Japanese postmenopausal patients
por: Shimizu, Tomohiro, et al.
Publicado: (2021)

Facilitation of β Selection and Modification of Positive Selection in the Thymus of Pd-1–Deficient Mice
por: Nishimura, Hiroyuki, et al.
Publicado: (2000)

The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002)

γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

Refinements in the reconstruction of bisphosphonate-related osteonecrosis of the jaw
por: Maeda, Taku, et al.
Publicado: (2022)

Quantitative bone single photon emission computed tomography analysis of the effects of duration of bisphosphonate administration on the parietal bone
por: Hata, Hironobu, et al.
Publicado: (2020)

CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets
por: Kashima, Jumpei, et al.
Publicado: (2022)

Bisphosphonates for osteoarthritis
por: Walsh, David A, et al.
Publicado: (2011)

Bisphosphonates: An update
por: Ganapathy, Nalliappan, et al.
Publicado: (2012)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging
por: Fakhrejahani, Elham, et al.
Publicado: (2015)

Enteroendocrine Cells Are Specifically Marked by Cell Surface Expression of Claudin-4 in Mouse Small Intestine
por: Nagatake, Takahiro, et al.
Publicado: (2014)

Rap1 signal modulators control the maintenance of hematopoietic progenitors in bone marrow and adult long‐term hematopoiesis
por: Imai, Takahiko, et al.
Publicado: (2019)

Surgical Results of Lumbar Interbody Fusion Using Calcium Phosphate Cement
por: HIRASAWA, Motohiro, et al.
Publicado: (2014)

Prodrugs for Amines
por: Simplício, Ana L., et al.
Publicado: (2008)

Antiparkinson Prodrugs
por: Di Stefano, Antonio, et al.
Publicado: (2008)

Dendrimer Prodrugs
por: da Silva Santos, Soraya, et al.
Publicado: (2016)

The potential role of Osteopontin in the maintenance of commensal bacteria homeostasis in the intestine
por: Ito, Koyu, et al.
Publicado: (2017)

Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
por: Najjar, Anas, et al.
Publicado: (2020)

Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates
por: Nagashima, Masakazu, et al.
Publicado: (2012)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Hassall’s corpuscles with cellular-senescence features maintain IFNα production through neutrophils and pDC activation in the thymus
por: Wang, Jianwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_07nn2htqgf9vsf6bad1nh5hl30